Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Alzheimer's disease & dementia

Researchers use AI to predict, detect Alzheimer's disease

Researchers at West Virginia University have identified a set of diagnostic metabolic biomarkers that can help them develop artificial intelligence tools to detect Alzheimer's disease in its early stages, as well as determine ...

Neuroscience

Oxytocin: The love hormone that holds the key to better memory

Oxytocin (OXT) is a hormone that is known for its effects on psychological well-being and emotional bonding in animals. Interestingly, research has shown that this natural chemical in the brain plays a crucial role in other ...

Alzheimer's disease & dementia

Novel blood metabolite biomarkers linked to Alzheimer's disease

Alzheimer's disease (AD) is the most common form of dementia and affects memory and thinking in the elderly. With a projected global increase in the number of affected individuals, reaching an estimated 152.8 million by 2050, ...

Neuroscience

Immune genes are altered in Alzheimer's patients' blood

A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients is epigenetically altered. That means the patients' behavior or environment has caused changes that affect the way their genes ...